medrxiv Subject Collection: Pain Medicine Palliative Medicine
http://medrxiv.org
This feed contains articles for medRxiv Subject Collection "Pain Medicine Palliative Medicine"
medrxivmedrxivhttps://www.medrxiv.org/sites/default/files/medrxiv_internal_logo.png
http://medrxiv.org
<![CDATA[
Meeting the needs of people with pulmonary fibrosis: patient perspectives on improving palliative care provision: a qualitative study
]]>
https://www.medrxiv.org/content/10.64898/2026.09.28.26364170v1?rss=1
2026-10-02doi:10.64898/2026.09.28.26364170Cold Spring Harbor Laboratory2026-10-02
<![CDATA[
Relevance-Based Prediction: A Transparent, Patient-SpecificApproach to Predicting Medical Outcomes
]]>
https://www.medrxiv.org/content/10.64898/2026.09.28.26364225v1?rss=1
2026-09-30doi:10.64898/2026.09.28.26364225Cold Spring Harbor Laboratory2026-09-30
<![CDATA[
Six recommendations for improving care and support in advanced COPD: evidenced from a population-based, mixed method, multiple-perspective, longitudinal study
]]>
https://www.medrxiv.org/content/10.64898/2026.09.29.26364287v1?rss=1
2026-09-30doi:10.64898/2026.09.29.26364287Cold Spring Harbor Laboratory2026-09-30
<![CDATA[
The Context of Recovery Among Adults Who Recover from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post-COVID Condition Following Mind-Body Approaches: A Qualitative Descriptive Study Protocol
]]>
https://www.medrxiv.org/content/10.64898/2026.09.24.26363855v1?rss=1
2026-09-25doi:10.64898/2026.09.24.26363855Cold Spring Harbor Laboratory2026-09-25
<![CDATA[
EasyCog: a fast and effective numerical tool for the self-assessment of cognitive functions
]]>
https://www.medrxiv.org/content/10.64898/2026.09.23.26363767v1?rss=1
2026-09-24doi:10.64898/2026.09.23.26363767Cold Spring Harbor Laboratory2026-09-24
<![CDATA[
Healthcare Worker s (HCWs) Knowledge and Attitudes Related to Pain Management in a Lebanese Tertiary Hospital
]]>
https://www.medrxiv.org/content/10.1101/2025.10.28.25336335v1?rss=1
0.05). However, age and profession showed a statistical significance of impact on the mean score of correct answers among HCWs (P <0.05), suggesting that these factors may influence pain management understanding among HCWs
CONCLUSIONThe findings highlight gaps in knowledge and attitudes toward pain management among HCWs. Structured education and training programs on pain management are deemed necessary to enhance the knowledge and attitudes of HCWs for better patient outcomes.
WHAT IS ALREADY KNOWN ON THIS TOPICPain is an undertreated clinical symptom and health burden affecting both hospitalized and non-hospitalized patients. Although pain has been designated as the 5th vital sign to ensure pain assessment and management, many patients continue to have uncontrolled or inadequate management of pain (1)(2). This negatively impacts the patients quality of life and overall wellbeing (2). A lack of adequate knowledge among HCWs remains a significant barrier to effective pain management (12), with misconceptions about pain evaluation; incorrect beliefs that patients overstate their pain; fears about drug tolerance and addiction; a lack of understanding of analgesic pharmacology; and difficulties in assessing pain in children (13).
WHAT THIS STUDY ADDSTo date, there are no published studies that assessed the knowledge and attitudes of physicians, nurses, and pharmacists toward pain management in Lebanon. Conducting such research is essential to identify discipline-specific gaps and inform strategies to improve pain management knowledge and clinical practice among physicians, nurses, and pharmacists alike.
]]>2025-11-01doi:10.1101/2025.10.28.25336335Cold Spring Harbor Laboratory2025-11-01
<![CDATA[
Assessing Pain Catastrophizing Through Free-Text Responses: A Validation of Large Language Models
]]>
https://www.medrxiv.org/content/10.64898/2026.07.22.26358710v1?rss=1
2026-07-27doi:10.64898/2026.07.22.26358710Cold Spring Harbor Laboratory2026-07-27
<![CDATA[
Development and Psychometric Validation of the Pelvic Dystonia Severity Scale (PDSS)
]]>
https://www.medrxiv.org/content/10.64898/2026.07.24.26358500v1?rss=1
2026-07-29doi:10.64898/2026.07.24.26358500Cold Spring Harbor Laboratory2026-07-29
<![CDATA[
Pain-Reporting Variability and Reliability as Predictors of Placebo Effects: A Cross-Sectional Experimental Pain Study
]]>
https://www.medrxiv.org/content/10.64898/2026.07.31.26359372v1?rss=1
2026-08-05doi:10.64898/2026.07.31.26359372Cold Spring Harbor Laboratory2026-08-05
<![CDATA[
Analgesic Efficacy of Native Himalayan Shilajit as Add-On Therapy in Myofascial Pain Syndrome: An Exploratory Pilot Clinical Trial
]]>
https://www.medrxiv.org/content/10.64898/2026.07.24.26357716v1?rss=1
4 were enrolled. Native Himalayan Shilajit 250 mg daily was administered as add-on therapy for 49 days. The main outcome was the percentage of participants with [≥]30% VAS reduction at Day 49. The intensity of pain, the dose of analgesics consumed and the number of trigger points were evaluated at five time points (Day 0, 12, 24, 36, 49). Throughout, adverse events were monitored.
RESULTSOf 80 enrolled participants, 76 (95.0%) completed the per-protocol analysis. Mean age was 41.25 {+/-} 9.05 years; 52.6% were male. A total of 56 of 76 participants (73.7%; 95% CI: 62.1- 82.8%) achieved the primary endpoint. Mean VAS score declined from 6.63 {+/-} 1.08 at baseline to.63 {+/-} 1.72 at Day 49 (mean reduction 45.3%; Friedman {chi}2 = 278.5, p<0.001). The first signs of pain reduction were seen at Day 24. The number of analgesic doses consumed decreased by 75.5% during the study period ({chi}2 = 126.1, p<0.001). There was a significant reduction in trigger point count from baseline to Day 49 (p=0.031) of 23.4%. One Grade 2 adverse event (gastrointestinal irritation, Day 28, resolved within 24 hours, no drug discontinuation) occurred; no serious adverse events were reported. Trial registration: CTRI/2025/06/088636. The study was not funded by any external sources.
CONCLUSIONSNative Himalayan Shilajit 250 mg/day for 49 days was associated with clinically and statistically significant reductions in pain intensity, analgesic consumption, and trigger-point burden in patients with MPS, with a favorable safety profile. These findings warrant confirmation in a larger, randomized, placebo-controlled trial.
]]>2026-08-05doi:10.64898/2026.07.24.26357716Cold Spring Harbor Laboratory2026-08-05
<![CDATA[
Multidimensional symptom burden across sleep, pain, affect, cognition and energy: cross-sectional associations with chronic pain interference and work disability in UK Biobank
]]>
https://www.medrxiv.org/content/10.64898/2026.08.03.26359604v1?rss=1
2026-08-07doi:10.64898/2026.08.03.26359604Cold Spring Harbor Laboratory2026-08-07
<![CDATA[
Biobehavioral pain profiling of minoritized adults with chronic widespread pain and clinical obesity before and after bariatric surgery: study protocol for a longitudinal, observational cohort study
]]>
https://www.medrxiv.org/content/10.64898/2026.08.04.26359660v1?rss=1
2026-08-08doi:10.64898/2026.08.04.26359660Cold Spring Harbor Laboratory2026-08-08
<![CDATA[
Neural Alterations in Chronic Pain: MRI Analysis
]]>
https://www.medrxiv.org/content/10.64898/2026.08.05.26359702v1?rss=1
2026-08-10doi:10.64898/2026.08.05.26359702Cold Spring Harbor Laboratory2026-08-10
<![CDATA[
Relevance Based Prediction: A Transparent, Non-Artificial Intelligence, Mathematical Solution to Personalized Opioid Treatment
]]>
https://www.medrxiv.org/content/10.64898/2026.08.07.26359966v1?rss=1
2026-08-11doi:10.64898/2026.08.07.26359966Cold Spring Harbor Laboratory2026-08-11
<![CDATA[
Targeted Pulsed Radio Frequency (PRF) Stimulation in the Management of Diabetic Peripheral Neuropathy: A Randomized, Single-Blind, Placebo-Controlled Trial
]]>
https://www.medrxiv.org/content/10.64898/2026.08.07.26359945v1?rss=1
2026-08-13doi:10.64898/2026.08.07.26359945Cold Spring Harbor Laboratory2026-08-13
<![CDATA[
Pain and Pain Sensitivity Assessments in the Acute to Chronic Pain Signatures (A2CPS) Program
]]>
https://www.medrxiv.org/content/10.64898/2026.08.14.26360457v1?rss=1
2026-08-19doi:10.64898/2026.08.14.26360457Cold Spring Harbor Laboratory2026-08-19
<![CDATA[
Pain on the Street: Implementation of a Field-Based Pain Response for People Experiencing Homelessness
]]>
https://www.medrxiv.org/content/10.64898/2026.08.13.26360409v1?rss=1
2026-08-20doi:10.64898/2026.08.13.26360409Cold Spring Harbor Laboratory2026-08-20
<![CDATA[
Peripheral magnetic stimulation of the upper-limb nerves: evoked sensations, phantom-pain relief, and cortical responses
]]>
https://www.medrxiv.org/content/10.64898/2025.12.05.25341696v1?rss=1
2026-08-21doi:10.64898/2025.12.05.25341696Cold Spring Harbor Laboratory2026-08-21
<![CDATA[
Longitudinal Characterization of Nociplasticity in Systemic Lupus Erythematosus: A Nationwide Registry Study
]]>
https://www.medrxiv.org/content/10.64898/2026.08.20.26360943v1?rss=1
2026-08-27doi:10.64898/2026.08.20.26360943Cold Spring Harbor Laboratory2026-08-27
<![CDATA[
Pain state-dependent multimodal assessment in non-specific low back pain: a pseudorandomized study design with implementation insights
]]>
https://www.medrxiv.org/content/10.64898/2026.08.26.26359760v1?rss=1
2026-09-03doi:10.64898/2026.08.26.26359760Cold Spring Harbor Laboratory2026-09-03
<![CDATA[
Enhancing Palliative Care Registration Using an Automated Robotic Process with Clinician Validation: A PRADA Prospective Cohort Study
]]>
https://www.medrxiv.org/content/10.1101/2025.08.27.25334555v1?rss=1
2025-11-13doi:10.1101/2025.08.27.25334555Cold Spring Harbor Laboratory2025-11-13
<![CDATA[
Factors associated with therapeutic complexity at the end of life: Analysis of a cohort of patients undergoing palliative care at home
]]>
https://www.medrxiv.org/content/10.1101/2025.11.10.25339944v1?rss=1
2025-11-15doi:10.1101/2025.11.10.25339944Cold Spring Harbor Laboratory2025-11-15
<![CDATA[
Factors associated with therapeutic complexity at the end of life: Analysis of a cohort of patients undergoing palliative care at home
]]>
https://www.medrxiv.org/content/10.1101/2025.11.10.25339944v1?rss=1
2025-11-15doi:10.1101/2025.11.10.25339944Cold Spring Harbor Laboratory2025-11-15
<![CDATA[
Understanding the Meaning of a Good Death for People living with Parkinsons Disease: Qualitative study
]]>
https://www.medrxiv.org/content/10.1101/2025.11.17.25340426v1?rss=1
2025-11-21doi:10.1101/2025.11.17.25340426Cold Spring Harbor Laboratory2025-11-21
<![CDATA[
Understanding the Meaning of a Good Death for People living with Parkinsons Disease: Qualitative study
]]>
https://www.medrxiv.org/content/10.1101/2025.11.17.25340426v1?rss=1
2025-11-21doi:10.1101/2025.11.17.25340426Cold Spring Harbor Laboratory2025-11-21
<![CDATA[
'I need policymakers to listen: a stakeholder needs assessment concerning anticipatory injectable medication systems, using a novel qualitative survey
]]>
https://www.medrxiv.org/content/10.64898/2026.01.02.26343333v1?rss=1
2026-01-05doi:10.64898/2026.01.02.26343333Cold Spring Harbor Laboratory2026-01-05
<![CDATA[
'I need policymakers to listen: a stakeholder needs assessment concerning anticipatory injectable medication systems, using a novel qualitative survey
]]>
https://www.medrxiv.org/content/10.64898/2026.01.02.26343333v1?rss=1
2026-01-05doi:10.64898/2026.01.02.26343333Cold Spring Harbor Laboratory2026-01-05
<![CDATA[
An external, contemporary evaluation of the Epic End of Life Care Index among hospitalized patients across two large health systems: A retrospective cohort study
]]>
https://www.medrxiv.org/content/10.64898/2026.01.02.26343350v1?rss=1
2026-01-06doi:10.64898/2026.01.02.26343350Cold Spring Harbor Laboratory2026-01-06
<![CDATA[
Support needs, support use and perceived helpfulness of support in a cohort of people bereaved during the COVID-19 pandemic: Insights from a longitudinal survey
]]>
https://www.medrxiv.org/content/10.64898/2026.01.06.26343556v1?rss=1
2026-01-09doi:10.64898/2026.01.06.26343556Cold Spring Harbor Laboratory2026-01-09
<![CDATA[
How does palliative care fit into national health spending? A secondary analysis of trends in long-term healthcare expenditure in the United Kingdom
]]>
https://www.medrxiv.org/content/10.64898/2026.01.23.26344608v1?rss=1
2026-01-28doi:10.64898/2026.01.23.26344608Cold Spring Harbor Laboratory2026-01-28